Page 5 - I Mab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from I mab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In I Mab Today - Breaking & Trending Today

I-Mab (IMAB) to Release Earnings on Friday

I-Mab (NASDAQ:IMAB – Get Rating) is set to announce its earnings results before the market opens on Friday, March 31st. Investors interested in listening to the company’s conference call can do so using this link. I-Mab Stock Performance Shares of NASDAQ:IMAB opened at $3.14 on Wednesday. I-Mab has a 52-week low of $2.73 and a […] ....

United States , Blackrock Inc , Goldman Sachs Group Inc , Jpmorgan Chase Co , America Corp , Vanguard Group Inc , Get Rating , Sachs Group , I Mab Daily , I Mab , Nasdaq Imab ,

I-Mab to Report Full Year 2022 Financial Results and Provide Corporate Update on March 31, 2023

/PRNewswire/ I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization. ....

United States , Hong Kong , San Diego , Emilie Wu , Gigi Feng , Richard Yeh , Company Nasdaq , Piacente Group Inc , Operating Officer , Chief Financial , Piacente Group , I Mab ,

MSCI ESG Updated I-Mab to "A" Rating

/PRNewswire/ I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization. ....

United States , Hong Kong , San Diego , Emilie Wu , Chun Kwok Alan , Gigi Feng , Richard Yeh , Prnewswire The Company Nasdaq , Piacente Group Inc , Morgan Stanley Capital International , Exchange Commission , Securities Litigation Reform Act , Operating Officer , Chief Financial , Piacente Group , I Mab ,

I-Mab Announces Two Poster Presentations of CD47 Antibody Lemzoparlimab at ASH 2022

/PRNewswire/ I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization. ....

United States , New Orleans , Hong Kong , San Diego , Macau General , Chunkang Chang , Emilie Wu , Andrew Zhu , Gigi Feng , Fanny Zhang , Richard Yeh , Prnewswire The Company Nasdaq , Ernestn Morial Convention Center , Piacente Group Inc , Exchange Commission , American Society Of Hematology , American Society , Annual Meeting , Biomarker Analyses , Therapeutic Mechanism , Shanghai Sixth People , Drug Resistance , Myeloid Neoplasms , Convention Center , Therapeutic Effects , Refractory Multiple ,

I-Mab Announces Share Purchase Plans by the Company and the Senior Management

/PRNewswire/ I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and. ....

United States , Hong Kong , San Diego , Emilie Wu , Gigi Feng , Jingwu Zang , Richard Yeh , Company American Depositary , Company Nasdaq , Company Board Of Directors , Piacente Group Inc , Exchange Commission , Acting Chief Executive Officer , American Depositary Shares , Securities Litigation Reform Act , Piacente Group , I Mab ,